Clinical Trials Logo

Clinical Trial Summary

This study is a randomized, double-blind, crossover trial aiming at evaluating the gastrointestinal tolerance of 3 sugar replacers mixes at 3 different doses. The investigators will also try to understand the factors that could explain the presence or absence of symptoms


Clinical Trial Description

This study is a randomized, double-blind, crossover trial with 23 visits consisting of one screening visit, one baseline visit, and 21 study visits (10 test periods each consisting of 2 test visits and one drop-off visit) across 11 weeks. For this study, 60 generally healthy subjects will be randomized to a test sequence and will consume one control product and nine test products over the course of the study. Before consumption of any study products, breath hydrogen lactulose assessment and collection of stool samples for microbiome analysis will be completed. Additionally, midway through the study, data will be reviewed in a blinded manner and a stool sample will be collected from a subset of 30 subjects for in vitro fermentation tests. Gastrointestinal symptoms and stool information will be collected using the Gastrointestinal Tolerance Questionnaire (GITQ) and Bowel Habit Diary with Bristol Stool Scale (BHD-BSS). The GITQ and BHD-BSS will be administered for 3 days and 7 days prior to study product consumption, respectively. Additionally, the GITQ and BHD-BSS will be collected throughout the day of study product consumption and the 2 days after product consumption. 24-h urine samples will be collected after study product consumption for urinary allulose analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05794100
Study type Interventional
Source Mondelez International, Inc.
Contact
Status Completed
Phase N/A
Start date October 11, 2021
Completion date July 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT05592951 - Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers N/A
Completed NCT04689035 - A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144 Phase 1
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Completed NCT06114524 - Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation N/A
Active, not recruiting NCT06286488 - Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza Phase 4
Completed NCT04529759 - Healthy Term Infants Fed Milk-Based Infant Formula N/A
Not yet recruiting NCT05428748 - Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers N/A
Completed NCT04499482 - Safety and Tolerability of Soy Fiber N/A
Recruiting NCT01207206 - Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients N/A
Completed NCT01038882 - Randomized Study With Midazolam for Sedation in Flexible Bronchoscopy N/A
Completed NCT06187233 - The Effects of Binaural Beats on Pain, Anxiety, and Procedure Tolerance in Patients Undergoing Colonoscopy Without Sedation N/A
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Recruiting NCT03707262 - Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor Phase 1/Phase 2
Completed NCT05585762 - Buck Institute Ketone Ester RCT N/A
Completed NCT02307773 - Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy N/A
Completed NCT04188782 - Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure
Recruiting NCT05527652 - Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia N/A
Recruiting NCT05088694 - The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain. N/A
Completed NCT06034951 - Acceptability and Tolerance Study of a High Energy Tube Feed With Food Derived Ingredients N/A
Completed NCT02144402 - Growth of Healthy Term Infants Fed Formula Containing DHA-B N/A